Risk of Ischemic Complications Related to the Intensity of Triptan and Ergotamine Use
Neurol 67:1128-1134, Wammes-van der Heijden,E.A.,et al, 2006
Dopamine Agonists and Cardiac Valvulopathy in Parkinson Disease: A Case-Control Study
Neurol 67:1225-1229, Yamamoto,M.,et al, 2006
Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006
Glioma Therapy in Adults
The Neurologist 12:279-292, Norden,A.D. &Wen,P.Y., 2006
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Spectrum and Prognosis of Neurologic Complications After Hematopoietic Transplantation
Neurol 67:1990-1997, Denier,C.,et al, 2006
Brain Metal Concentrations in Chronic Liver Failure Patients With Pallidal T1 MRI Hyperintensity
Neurol 67:1984-1989, Klos,K.J.,et al, 2006
Psychotropic Effects of Antiepileptic Drugs
Neurol 67:1916-1925, Ettinger,A.B., 2006
Seizures During Stroke Thrombolysis Heralding Dramatic Neurologic Recovery
Neurol 67:2048-2049, Rodan,L.H.,et al, 2006
Retinopathy in Survivors of Primary Central Nervous System Lymphoma
Neurol 67:2060-2062, Grimm,S.A.,et al, 2006
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005
Meningoencephalitis caused by Streptococcus Pneumoniae: A Diagnostic and Therapeutic Challenge
Neurorad 47:758-764, Jorens, P.G.,et al, 2005
Intracranial Haemorrhages in French Haemophilia Patients (1991-2001): Clinical Presentation, Management and Prognosis Factors for Death
Haemophilia 11:452-458, Stieltjes,N.,et al, 2005
Chasing "Chasing the Dragon" with MRI: Leukoencephalopathy in Drug Abuse
Br J Radiol 78:997-1004, Bartlett,E. &Mikulis,D.J., 2005
Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Neurorehabil Neural Repair 19:259-263, Dobkin,B.H., 2005
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
Verapamil Induced Gingival Enlargement in Cluster Headache
JNNP 76:124-127, Matharu,M.S.,et al, 2005
Postcarotid Endarterectomy Hyperperfusion or Reperfusion Syndrome
Stroke 36:21-26, Karapanayiotides,T.,et al, 2005
Painful Peripheral Neuropathy Associated with Voriconazole Use
Arch Neurol 62:144-146, Tsiodras,S.,et al, 2005
Intermittent Prednisone Therapy in Duchenne Muscular Dystrophy
Arch Neurol 62:128-132, Beenakker,E.A.C.,et al, 2005
Amorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease
Neurol 64:392-393, Pot, C., et al, 2005
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
JAMA 293:427-436, The CREATE Trial Group Investigators, 2005
Carbamazepine and False Positive Dexamethasone Suppression Tests for Cushing's Syndrome
BMJ 330:299-300, Ma., R.C.W., et al, 2005
Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005
Steroid Dementia: an Overlooked Diagnosis?
Neurol 64:707-709, Sacks,O. & Shulman,M., 2005
Continued Use of Zonisamide Following Development of Renal Calculi
Neurol 64:763-764, Richards, K.C., et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Acute Tetrodotoxin-Induced Neurotoxicity After Ingestion of Puffer Fish
Ann Neurol 57:339-348, 309, Kiernan, M.C., et al, 2005
Effects of Topiramate and Gabapentin on Cognitive Abilities in Healthy Volunteers
Neurol 64:792-798, Salinsky, M.D., et al, 2005
Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005
"Levodopa Phobia": A New Iatrogenic Cause of Disability in Parkinson Disease
Neurol 64:923-924, Kurlan, R., 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
NEJM 352:987-996, 1036, Stupp,R., et al, 2005
MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma
NEJM 352:997-1003, 1036, Hegi,M.E., et al, 2005
Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
NEJM 352:10 978-986, 1036, Rutkowski,S., et al, 2005
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Visual Field Defect and Intracerebral Hemorrhage Associated with use of Vardenafil (Levitra)
Neurol 64:1095, McGee,H.T., et al, 2005
Increased Rate of Major Malformations in Offspring Exposed to Valproate Durng Pregnancy
Neurol 64:961-965, 938, Wyszynski,D.F., et al, 2005
Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005
Neuropsychological Effects of Exposure to Anticonvulsant Medication in Utero
Neurol 64:949-954, 938, Vinten,J., et al, 2005
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
NEJM 352:1324-1334, 1373, Gilron,I.,et al, 2005
Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005
Clinicopath Conf, Human Granulocytic Ehrlichiosis
NEJM 352:1358-1364, Case 10-2005, 2005
Safety and Efficacy of Endovascular Treatment of Carotid Artery Stenosis Compared with Carotid Endarterectomy
Stroke 36:905-911, Coward,L.J., et al, 2005
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005
Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in New Users of Antiepileptics
Neurol 64:1134-1138, Mockenhaupt,M.,et al, 2005